Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
33 papers
Recent·Most cited
W. Sun, S. McCroskery, W.-C. Liu…·P. Palese
This paper evaluates an inactivated Newcastle disease virus expressing the SARS-CoV-2 spike protein as a cost-effective vaccine, showing immunogenicity and protective efficacy in animal models.
W. Sun, S. R. Leist, S. McCroskery…·P. Palese
This paper describes NDV vector vaccines expressing SARS-CoV-2 spike protein that protect mice from viral challenge and can be produced cost-effectively in chicken eggs.
R. Rathnasinghe, S. Strohmeier, F. Amanat…·M. B. Uccellini
This study compares two SARS-CoV-2 infection models in mice: K18-hACE2 transgenic and adenovirus-mediated hACE2 delivery, showing differences in viral replication and disease outcomes.